Pipeline

TVG has established a pipeline of animal vaccines that address infectious diseases in animals that are either zoonotic, transferred from animals to humans, or have a serious commercial impact on livestock production. We have an international network of collaborators and are funded by a number of sponsors, including the UK, Chinese and US governments. 

Pipeline

Overview of TVG’s current in vitro R&D pipeline.

TVG's Animal Vaccines Pipeline

African Swine Fever

Internally funded. 

SARS-CoV-2

Internally funded. 

S. suis

Funded by Innovate UK and Chinese government. 

E. coli mastitis

In collaboration with University of Liège and University of Plymouth 

Funded by BactiVac

PRRSV

In collaboration with the Pirbright Institute. 

Funded by ECO Animal Health.

TB

Funded by Defra, ongoing work internally funded. 

Lassa fever

In collaboration with UC Davis, Heinrich Pette Institute, University of Western Australia, University of Idaho, University of Glasgow, University of Makeni and the National Institute of Allergy and Infectious Diseases. 

Funded by DARPA. 

Ebola

In collaboration with UC Davis, Heinrich Pette Institute, University of Western Australia, University of Idaho, University of Glasgow, University of Makeni and the National Institute of Allergy and Infectious Diseases. 

Funded by DARPA.